Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.
about
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathwaySilk fibroin-based nanoparticles for drug deliveryGrowth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering.Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor.Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs.Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice.Tissue engineered perivascular endothelial cell implants regulate vascular injury.Tissue average binding and equilibrium distribution: an example with heparin in arterial tissues.Sciatic nerve regeneration using a nerve growth factor-containing fibrin glue membraneLocal delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty.Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenograftsBasic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.The Effect of Control-released Basic Fibroblast Growth Factor in Wound Healing: Histological Analyses and Clinical Application.Growth factor delivery for bone tissue engineering.Tissue engineering strategies for in vivo neovascularisation.Therapeutic angiogenesis: protein-based therapy for coronary artery disease.Ordered and kinetically discrete sequential protein release from biodegradable thin films.Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxelCytokine therapy for craniosynostosis.Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.Therapeutic angiogenesis for myocardial ischemia.The role of the adventitia in vascular inflammation.Matrix-based gene delivery for tissue repairDegradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularizationThe influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells.Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions.Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factorAngiogenic gene therapy for refractory angina.Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation.A bio-inspired hybrid nanosack for graft vascularization at the omentum.Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention.Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.A novel cell-containing device for regenerative medicine: biodegradable nonwoven filters with peripheral blood cells promote wound healing.Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate bindingThe role of neurotrophic factors conjugated to iron oxide nanoparticles in peripheral nerve regeneration: in vitro studies.Optimal amount of basic fibroblast growth factor in gelatin sponges incorporating β-tricalcium phosphate with chondrocytesSilica-chitosan hybrid coating on Ti for controlled release of growth factors.Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro.
P2860
Q24649727-3A556AEE-1427-406E-88F4-00A2C0C5BFF1Q26995026-DA8A9829-53DB-4747-81B7-29F9FE2C059AQ30488316-5E079C24-AE91-4BAA-86E3-8CD4EE78B00FQ31097426-D0D39FEB-E258-4106-8A56-572756D57D58Q32063516-A4A2E8FD-D563-44E2-BFB9-05DD3C26C2F7Q33585394-6C96A1C9-D5BB-4D04-AEDD-0C4EBF87AFAAQ33949676-94E8BF6A-96D3-4325-8409-C1501D63BD04Q34017491-47AAA429-8127-4513-A26B-490BF89D0DE2Q34095039-13E061B3-F862-4644-B773-25291452E5C1Q34133379-BDF85C48-00E1-41E5-BBC1-9C3A80E677A6Q34170606-79BE65AC-8E9E-4070-B8A6-18E1160C66B1Q34228938-5EDB2AC0-AB7F-4FCA-97DF-F8FB52BC7618Q34239474-8B07280E-943E-4B6A-8A35-935D19D69913Q34513981-08169F18-C4E4-41CF-886C-BFD677C6F150Q35040815-18A4BCED-0861-4D09-BF81-F92D1FE0EABAQ35058121-A08BF00B-1971-40B7-8672-9B919D259C0DQ35295689-DE19D890-6369-4F33-9816-7F3EEC8DA5C8Q35321625-E0BE2CEB-2568-47AC-9B28-BEBC4C986676Q35684846-EE591B06-A53A-41B8-B7CF-EA17E11A63EEQ35693444-5FFE1B1E-9101-44CD-819A-EABEA05DABDCQ35777375-7D494B05-013C-458C-9D69-878CB558FDC2Q36896406-C1822255-02F0-4565-AC58-4E10B55C9033Q37164780-43470B10-9CC0-484D-BDF9-26A0696201C8Q37177994-2E7CA14E-5BB9-445E-B94F-0611BAF54660Q37345194-8BCB0E9C-E49F-4EAF-9489-0AE6A1B62BF5Q37885356-55391F7A-CFED-48F2-B0C5-9688DBADD4A1Q38294916-E891DC44-144D-4EFE-9D37-83DB8CBCF6D4Q38303388-DF9DEED6-8620-4447-9B80-FB8862F33D2CQ38637597-8E805E4B-5338-4AEA-8B59-3E89706BC79BQ39010222-EBC78DA4-C5B1-4898-956B-2C1A9021112BQ39693090-31453B60-2DA9-4481-8AE6-42950C2A2E2AQ40486878-C7FF384E-7FC9-4448-BFF5-F2048C50790BQ40810334-1A1FF805-39D4-4B4F-A2C8-B5F34866E719Q40886686-860AF7A4-B04B-4F95-99F1-A6E31AB95ED8Q41807041-6A65C794-FC50-4046-9EA5-CA60953FFE1BQ42181057-3D9F1434-9C0D-4EAE-A1A5-42F5F0BD68ECQ42556394-68D18360-BC24-43BE-BA8B-40BC96602362Q42804245-DCD34FFC-2035-4D40-886F-223C226C3F67Q42806631-581EBA43-4B09-48A2-9B71-DE6FEB672BDDQ42828363-6631160D-DC22-489E-820D-1880544BA03C
P2860
Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Perivascular and intravenous a ...... ar and solid organ deposition.
@ast
Perivascular and intravenous a ...... ar and solid organ deposition.
@en
type
label
Perivascular and intravenous a ...... ar and solid organ deposition.
@ast
Perivascular and intravenous a ...... ar and solid organ deposition.
@en
prefLabel
Perivascular and intravenous a ...... ar and solid organ deposition.
@ast
Perivascular and intravenous a ...... ar and solid organ deposition.
@en
P2093
P2860
P356
P1476
Perivascular and intravenous a ...... ar and solid organ deposition.
@en
P2093
E R Edelman
M A Nugent
M J Karnovsky
P2860
P304
P356
10.1073/PNAS.90.4.1513
P407
P577
1993-02-01T00:00:00Z